HAPILA showing advanced drug CDMO services at Chemspec Europe


HAPILA showing advanced drug CDMO services at Chemspec Europe


HAPILA Logo 150 x 49

Press Release | HAPILA GmbH

JUNE 12, 2019

Gera, Germany: – High-potency active ingredient specialist CDMO HAPILA GmbH (HAPILA) is returning to the Chemspec Europe trade fair for fine and specialty chemicals in Basel to showcase its cGMP drug development and manufacturing services.

HAPILA will exhibit from Booth C36 in Hall 1.0 at Messe Basel as part of a joint showing by nine independent pharma and fine chemicals companies from central Germany. Together, they cover the entire value chain of organic fine chemicals and active ingredient production.

The HAPILA team in Basel will be led by CEO Dr. Uwe Müller and Head of the QA/QC Quality Unit, Dr. Steffen Wittmann.

New opportunities

This is the third year in succession that HAPILA has been present at Chemspec Europe and the company will again seek to use the event’s networking opportunities to cement existing and new partnerships.

“There will be ideal opportunities for our customers and for new interested potential partners as well to discuss the possibilities of interesting cooperative ventures and to explore new opportunities,” said Dr. Müller.

Adding API small molecule expertise

“We will be reaching out to decision makers in pharmaceutical companies, performing own drug development as well as generic companies looking for outsourcing or external support and SME’s and start-ups looking to develop new drugs with added API-experience in the field of small molecules,” Dr. Müller continued.

HAPILA’s offer includes fully IMPD and ASMF regulated services for APIs, a one-stop-shop value creation chain for new drug substances ranging from lab scale to 100L pilot plants, in house analytical investigations by its QC unit.

“We operate at an extremely high scientific and QA-level,” said Dr. Wittmann.

“Because we are a self-contained team, that means decisions can be made fast, efficiently, and directly in close cooperation with our customers,” Dr. Wittmann explained.

Covering the whole value chain

“Our nine companies from Central Germany will present their collective expertise at Chemspec Europe 2019,” noted Dr. Müller.

“With a broad portfolio of complementary capabilities, the assembled companies cover the wide value chain of organic fine chemicals and active ingredient production, ranging through feasibility studies, production of high quality organic chemicals and APIs to analysis of multi-tone scale, development and scale up of processes as well as regulatory support,” he explained.

“Thanks to the close networking and collaboration of the eight jointly exhibiting companies, our customers can benefit from efficient and tailor-made solutions and products,” he concluded.

About HAPILA GmbH

HAPILA GmbH is a Contract developer and manufacturer (CDMO) that provides high-value services to pharma, biotech and fine chemicals client companies in the development and cGMP manufacture of active pharmaceutical ingredients (APIs).

HAPILA is an independent company with particular experience in GMP-related development and GMP manufacturing, offering full regulated service for API (IMPD, ASMF) to very high scientific and quality assurance (QA) levels.

It supports the development and manufacture of drug products with patented processes and in-depth experience in the API value-creation chain from synthesis through purification to particle design.

The company’s mission is to supply exclusive products of highest quality, potency and safety in compliance with GMP and environmental protection guidelines. All HAPILA teamwork is focused on product quality and customer satisfaction.

All HAPILA chemical synthesis is carried out at in-house at its GMP certified laboratories at Gera, Thuringia, in east-central Germany.

When combined with purification and particle design, HAPILA’s chemical synthesis services cover the complete API value-creation chain, enabling it to be a highly efficient bridge-builder between API production and pharmaceutical end-use.

About Chemspec Europe 2019

The 34th International Exhibition for Fine and Specialty Chemicals, Chemspec Europe, is the continent’s premier sourcing and networking event for manufacturers, suppliers and distributors of fine and specialty chemicals. Chemspec Europe is renowned for its specialized profile, presenting visitors and exhibitors with a platform to share knowledge about products and solutions.

The 34th Chemspec Europe expo (Chemspec 2019) is a two-day event opening June 26 at the Messe Basel exhibition center in Basel, Switzerland. The previous Chemspec show, in Cologne, Germany, attracted more than 400 exhibitors from 29 countries and some 7,000 attendees from all over the world.

The event is organized by Mack-Brooks Exhibitions with further information at https://www.chemspeceurope.com

Media Contact

Dr. Uwe Müller, CEO, HAPILA GmbH
Tel: +49 365 205 86 930
Email: Uwe.mueller@hapila.de

Resources

Click on HAPILA at Chemspec Europe for other information.
Click on HAPILA GmbH to contact the company directly.

Hapila Chemspec


Supplier Information
Supplier: HAPILA GmbH
Address: Otto-Schott-Str. 9, 07552 Gera, Germany
Tel: +49 365 2058 6910
Fax: +49 365 2058 6939
Website: www.hapila.de/en/home.html


Comments are closed.